R. Gregory Bociek
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 75
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 53
- Oncology top 2%
- Viral-associated cancers and disorders 20
- CAR-T cell therapy research 11
- Neurology top 5%
- CNS Lymphoma Diagnosis and Treatment 10
- Hematology top 5%
- Multiple Myeloma Research and Treatments 8
-
- Acute Lymphoblastic Leukemia research 11
-
- Histone Deacetylase Inhibitors Research 6
- Co-authors
- Julie M. VoseJamés O. ArmitagePhilip J. BiermanDennis D. WeisenburgerWing C. ChanTimothy C. GreinerLynette M. SmithChristine P. Hans
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (8 papers)Blood (43 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
R. Gregory Bociek
114 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 103
- Pathology and Forensic Medicine 1.7k
- Genetics 927
- Oncology 1.3k
- Neurology 383
- Hematology 248
Countries citing papers authored by R. Gregory Bociek
This map shows the geographic impact of R. Gregory Bociek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Gregory Bociek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Gregory Bociek more than expected).
Fields of papers citing papers by R. Gregory Bociek
This network shows the impact of papers produced by R. Gregory Bociek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Gregory Bociek. The network helps show where R. Gregory Bociek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Gregory Bociek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2018 | 23 | |
| 6 | 2018 | 8 | |
| 7 | 2015 | 20 | |
| 8 | 2015 | 18 | |
| 9 | 2014 | 20 | |
| 10 | 2014 | 4 | |
| 11 | 2013 | 19 | |
| 12 | 2013 | 37 | |
| 13 | 2013 | 18 | |
| 14 | 2012 | 13 | |
| 15 | 2011 | 156 | |
| 16 | 2009 | 14 | |
| 17 | 2006 | 48 | |
| 18 | 2005 | 100 | |
| 19 | 2003 | 12 | |
| 20 | 1997 | 78 |
About R. Gregory Bociek
R. Gregory Bociek is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 119 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (75 papers), Chronic Lymphocytic Leukemia Research (53 papers), Viral-associated cancers and disorders (20 papers), CAR-T cell therapy research (11 papers), Acute Lymphoblastic Leukemia research (11 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Multiple Myeloma Research and Treatments (8 papers) and Histone Deacetylase Inhibitors Research (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.7k citations), Genetics (927 citations) and Oncology (1.3k citations). R. Gregory Bociek has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Julie M. Vose, Jamés O. Armitage, Philip J. Bierman, Dennis D. Weisenburger, Wing C. Chan, Timothy C. Greiner, Lynette M. Smith, Christine P. Hans, Patricia Aoun and Anas Younes. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.